The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency
Abstract Colon cancers with mismatch repair deficiency (dMMR) have specific clinicopathologic characteristics compared with mismatch repair proficiency (pMMR); however, the effect of MMR status on the efficiency of neoadjuvant chemotherapy (NCT) remains unclear. In our study, 439 dMMR and 26 pMMR co...
Main Authors: | Wu Yunlong, Liu Tongtong, Zeng Hua |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5076 |
Similar Items
-
The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study
by: Leen Liao, et al.
Published: (2024-02-01) -
Neoadjuvant chemotherapy for colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2022-06-01) -
Mismatch Repair Deficiency and Microsatellite Instability
by: Sandra Schöniger, et al.
Published: (2022-08-01) -
Spontaneous regression of advanced transverse colon cancer with deficient mismatch repair: a case report
by: Shinnosuke Harata, et al.
Published: (2023-04-01) -
Effect of mismatch repair genes expression in right colon cancer on pathological characteristics
by: YAN Wanneng, MA Haijie, SHEN Chaomin
Published: (2021-01-01)